The Ministry of Health, Welfare and Sport (Ministerie van
Volkgezondheid, Welzijn en Sport) has Announced That it Commences With
the Sale of the Production Activities of the 'Nederlands Vaccin
Instituut' (NVI). The Sales Process Starts on February 15, 2011.
THE HAGUE, The Netherlands, Feb. 15 /CNW/ - In January 2010 the Minister
of Health, Welfare and Sport informed the House of Representatives that
the NVI was going to change course. NVI's public tasks, concerning
procurement, warehousing and distribution of vaccines and the public
vaccine research and development tasks, are integrated into the Dutch
National Institute for Public Health and the Environment (RIVM) as per
1 January 2011. The production of vaccines under public ownership will
be ended. The production and the production facilities are put up for
sale to the private sector.
In the past NVI's production of vaccines played an important role in the
availability of vaccines and vaccines related technology worldwide. NVI
transferred its knowledge on vaccines mainly via the transfer of
technology and stem cells to various public and private institutions.
Within its modern and compliant production facilities, the production
entity in Bilthoven produces biopharmaceutical products such as viral
and bacterial vaccines. Over the years, various types of vaccines have
been produced in a validated and certified production environment.
The present manufacturing activities consist of the production of
inactivated polio vaccine (IPV) as bulk- or final product, BCG vaccines
used in after-surgery treatment of bladder cancer, the combined
diphtheria-tetanus-polio (DTP) vaccine and the tetanus toxoid (Ttox)
vaccine used in the vaccination of children and adults. Contract
manufacturing for third parties is within the scope of activities up
for sale. The production environment, located in the Antonie van
Leeuwenhoek Science Park in Bilthoven, meets the high standards of Good
The sale of NVI's production activities starts officially on February
15, American Appraisal has been appointed to act as advisor to the
Ministry of Health Welfare and Sport during the sale of the production
activities of NVI. All parties interested in the abovementioned sales
process should state their interest via American Appraisal, before
March 4, 2011.
SOURCE American Appraisal
For further information:
American Appraisal, Drs. Joachim Schulz, Managing Director, Head of Transaction Services Central Europe, Tel: +31-10-2092610, Fax: +31-10-4365305, firstname.lastname@example.org; Correspondence address: American Appraisal, Parklaan 44, 3016 BC Rotterdam, The Netherlands